- Patent Title: SARS-COV2 spike peptides that interact with HLA-DR1 and human TLR8
-
Application No.: US17346245Application Date: 2021-06-13
-
Publication No.: US11613562B2Publication Date: 2023-03-28
- Inventor: Subhajit Dasgupta
- Applicant: Subhajit Dasgupta
- Applicant Address: US SC Charleston
- Assignee: Subhajit Dasgupta
- Current Assignee: Subhajit Dasgupta
- Current Assignee Address: US SC Charleston
- Main IPC: C07K14/165
- IPC: C07K14/165
Abstract:
The multi-epitope SARS-COV2 Spike peptides are analyzed for their ability to form association or binding complex with HLA-DR1 and human TLR8 by using computer modeling and molecular docking experiments. These peptides are identified as candidates for vaccine development as well as antibody-based immunotherapy.
Public/Granted literature
Information query
